Imatinib Mesylate can induce complete molecular remission in FIP1L1-PDGFR-alpha positive idiopatic hypereosinophilic sindrome.

Authors
Publication date
1 January 2003
Publisher
'American Society of Hematology'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Brescia

    redirect
    oaioai:iris.unibs.it:11379/155583
    Last time updated on 12/11/2016